A total of 79 infants born at less than 32 weeks' gestation were studied with serial renal ultrasound scans to assess the incidence of nephrocalcinosis. Twenty one infants developed renal calcification giving an overall incidence of 26-6% in the study group. Affected infants were significantly smaller (mean (SD) birth weight 940 (323) g) and significantly less mature (mean (SD) gestation 26.9 (19) weeks). In 17 patients the calcification was represented by hyperechogenic renal pyramids alone, and in four patients renal calculi were demonstrated. Factors associated with renal calcification included hypophosphataemia, hypercalcaemia, hypercreatininaemia, and prolonged oxygen requirement during the first month of life. Multivariate analysis showed that the strongest clinical indicator of calcification was duration of oxygen treatment. Infants who still required oxygen treatment at 28 days had a 62% chance of developing renal calcification.
The tendency for calcium salts to deposit in the human renal tract has plagued mankind and provided employment for lithotomists for over 2000 years. Improved survival among preterm infants has resulted in a greater recognition of the complications of their medical management, which includes a risk of renal calcium deposition. The first reports of renal calcification appeared in 1982,' and subsequent reports continued to link it with hyfercalciuria and frusemide administration.2 Improvements in diagnostic ultrasound resulted in the increased recognition of this problem, and in 1988 Jacinto et al reported an incidence of 64% in infants below 1500 g birth weight. 4 This report was the first to describe the occurrence of renal calcification in the absence of frusemide treatment. Despite the suggestion that two out of every three infants below 1500 g birth weight are likely to be affected, reports of renal calcification continue to be sporadic. Only three cases have been described in Britain, all of whom have been treated with frusemide. 5 Factors that may contribute towards renal calcification include renal insufficiency, parenteral feeding, prolonged immobility, and bone demineralisation, all of which are commonly encountered in the sick preterm infant.
In view of the conflicting reports of the incidence of calcification in the face of known risk factors this study was designed to determine the incidence of and possible contributary factors towards renal calcification in preterm infants.
Patients and methods All infants born before 32 completed weeks' gestation and admitted to our neonatal intensive care unit within 24 hours of birth were eligible for the study. Infants born elsewhere and transferred after 24 hours of age were excluded, as were those who were discharged or died before 7 days of age. Recruitment occurred only after the first week of life. The study protocol was approved by the local ethics committee.
Clinical data was recorded for the duration of each infant's admission. This included diagnosis, gestation, birth weight, duration of ventilation and oxygen treatment, aminoglycoside, steroid, and diuretic treatment, and prescribed and actual intakes of enteral and parenteral feeds.
Weekly intakes of calcium and phosphate were calculated from prescribed supplements if parenterally fed and using published concentrations of calcium and phosphate if milk fed. Human expressed breast milk was assumed to contain 8-75 mmol/l of calcium and 4-85 mmol/l of phosphate. 6 Blood specimens were collected at least daily during periods of intensive care, and no less than weekly as the patients improved, to assess calcium, phosphate, and creatinine concentrations. Beyond 28 days of age serum alkaline phosphatase activity was measured once a week. Apart from creatinine, all biochemical analyses were performed using a Technicon autoanalyser in a clinical laboratory with staff experienced in handling neonatal specimens. Serum and urine creatinine estimation was by the Jaffe reaction.
After 7 days of age random urine specimens were collected at weekly intervals to measure calcium, phosphate, and creatinine concentrations. Calcium to creatinine ratios were calculated and tubular reabsorption of phosphate was determined using serum biochemical results from specimens obtained the same morning. Urine specimens were generally collected into a urine collecting bag but if this proved impractical then specimens were extracted from soaked napkins as described by Roberts (table 2) .
Serum urea and creatinine concentrations were both significantly greater in the affected patients indicating a greater degree of renal insufficiency. Despite the very high values in some cases no patient required dialysis and by 4 weeks of age there was no difference between the two groups ( fig 1) .
There was no significant difference in either calcium:creatinine ratio (4-4 (4-1) compared with 4-0 (2-9), p=047) or phosphate:creatinine ratio (15 (1-8) compared with 1-3 (1-7), p= 0-33) as measured on a molar:molar basis on specimens collected at 7 days of age. From 2 weeks of age, however, infants who subsequently developed renal calcification had significantly higher urinary calcium excretion. The difference was significant until week 6 after which small numbers of normal patients affected the statistical analysis (fig 2) .
To ensure that the higher calcium:creatinine ratios in the affected group did not simply reflect diminished renal function with poor urinary concentration, mean values for urinary calcium and creatinine concentrations were also calculated for the first month of life. These showed both signflcantly higher urine calcium 20 induced hypercalciuria is the predominant factor in aetiology is an oversimplication of the complex interaction of risk factors in these infants.
Assessment of urinary calcium excretion suggests that all preterm infants begin life with relative hypercalciuria. Although this tends to improve in the unaffected group, the tendency in the group with calcification is for a progressive increase in renal calcium excretion. This hypercalciuria is regularly detected before the introduction of frusemide, after which individual patients may show either increases or decreases in calciuria. The measurement of calcium:creatinine ratios on random specimens of urine has previously been validated," but there is no doubt that 24 hour urine collections give a more accurate indication of calcium excretion. The extraction of specimens from wet napkins may also lead to errors in estimation of urinary calcium, although prompt collection of urine once voided will minimise this problem. Due to renal impairment the sick preterm infants in our study showed diminished urinary creatinine concentration, more noticeably in the group with nephrocalcinosis. Although to interpret a high calcium:creatinine ratio in such circumstances as indicative of hypercalciuria may be wrong, it would appear that both higher calcium excretion and lower creatinine excretion contribute to the increased ratios.
We did not assess urinary stone inhibitors in this study. There is, however, some evidence suggesting that urinary citrate tends to fall with rises in urinary calcium, and urinary magnesium is also lower in infants with nephrocalcinosis who are receiving frusemide. " The role of urinary uric acid excretion in the aetiology of renal calcium deposition in preterm infants remains unclear.
In order for urinary crystallisation and stone formation to occur the urine must be supersaturated with calcium. Given a constant rate of calcium excretion urinary calcium saturation will be greater at times of low urinary production. We have not measured urine output in our patients, although it would seem likely that the raised serum creatinine concentrations in affected infants may have been accompanied by varying degrees of oliguria. Ezzedeen and colleagues identified oliguria (<1-5 ml/kg/hour) as a risk factor for renal calcification found in 59% of their cases, although no data are provided for suitably matched controls.3 If facilities are available for accurate monitoring of urine output, particuarly during the initial period of intensive care, then a documented period of oliguria may well be a further indicator of infants at risk of nephrocalcinosis.
Similarly acidosis has been suggested as a further risk factor for nephrocalcinosis,3 in view of the resulting increase in calcium excretion. However both metabolic and respiratory acidosis occur so commonly in sick preterm infants, whom we have already identified as the group at risk of renal calcification, that the presence of a low pH is unlikely to increase significantly the ability to identify potentially affected infants.
Hypercalciuria is a recognised consequence of hypophosphataemia, which we have demonstrated in our patients throughout the first month of life. There has been considerable interest in the role of phosphate intake in the aetiology of osteopenia of prematurity,'2 13 and it would appear that it is similarly implicated in renal calcium deposition. Exact phosphate requirements in sick preterm infants are difficult to establish, but recent reports suggest 1X4 mmol/kg/day may be the optimal figure.'4 15 The currently used parenteral feeding regime on our unit provides only half this amount, and may be partly responsible for the high incidence of nephrocalcinosis. Ensuring adequate phosphate intake would not only reduce hypercalciuria, it may also erradicate osteopenia of prematurity.'6 The solubility of phosphate in parenteral feeding solutions causes problems in administration, however, and caution is needed when prescribing phosphate supplements in the presence of appreciable hypercalciuria. Too much phosphate may result in the anticipated calcium deposition occurring renally rather than skeletally. 17 The high alkaline phosphatase activity that we found in our patients is not surprising given the intricate association between the skeleton and renal tract in calcium and phosphate homoeostasis. The 
